Media Coverage

Proteomics International has been granted a patent in the Russian Federation for the company’s break...

Proteomics International (PI) is pleased to provide an update on its clinical studies for PromarkerD...

Proteomics International and clinical trial specialists Linear Clinical Research Ltd (Linear) are se...

The Company today reached a strategic milestone in its commercialisation pathway for PromarkerD, the...

Proteomics International Laboratories Ltd (PILL) edged out shipbuilding giant Austal and Fortescue M...

Proteomics International has successfully applied its biomarker discovery platform Promarker to the ...

The Company is delighted to announce the appointment of Mr Roger Moore as a Non-Executive Director o...

The Company has been boosted by the receipt of more than half a million dollars in research and deve...

Proteomics International Laboratories Ltd (PILL, ASX: PIQ) has begun the detailed search for protein...

Proteomics International is investigating proteins in the blood that are associated with endometrios...

Proteomics International is pleased to announce that the company’s PromarkerD test for kidney diseas...

Proteomics International is pleased to announce significant advances towards commercialisation of Pr...

Proteomics International is pleased to provide update on the growth of its analytical services opera...

Proteomics International is pleased to announce the expansion of its operations in the massive India...

The Company is pleased to announce that it has commenced a Therapeutic Drug Discovery program utilis...

The Company is pleased to provide market update on PromarkerD.

Media release

The Company is pleased to provide update on its business activities for the three month period to 31...